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ABSTRACT Cryptococcus gattii R265 is a hypervirulent fungal strain responsible for
the recent outbreak of cryptococcosis in Vancouver Island of British Columbia in
Canada. It differs significantly from Cryptococcus neoformans in its natural environ-
ment, its preferred site in the mammalian host, and its pathogenesis. Our previous
studies of C. neoformans have shown that the presence of chitosan, the deacetylated
form of chitin, in the cell wall attenuates inflammatory responses in the host, while
its absence induces robust immune responses, which in turn facilitate clearance of
the fungus and induces a protective response. The results of the present investiga-
tion reveal that the cell wall of C. gattii R265 contains a two- to threefold larger
amount of chitosan than that of C. neoformans. The genes responsible for the bio-
synthesis of chitosan are highly conserved in the R265 genome; the roles of the
three chitin deacetylases (CDAs) have, however, been modified. To deduce their
roles, single and double CDA deletion strains and a triple CDA deletion strain were
constructed in a R265 background and were subjected to mammalian infection stud-
ies. Unlike C. neoformans where Cda1 has a discernible role in fungal pathogenesis,
in strain R265, Cda3 is critical for virulence. Deletion of either CDA3 alone or in com-
bination with another CDA (cda13Δ or cda23) or both (cda123) rendered
the fungus avirulent and cleared from the infected host. Moreover, the cda1Δ2Δ3Δ
strain of R265 induced a protective response to a subsequent infection with R265.
These studies begin to illuminate the regulation of chitosan biosynthesis of C. gattii
and its subsequent effect on fungal virulence.
IMPORTANCE The fungal cell wall is an essential organelle whose components pro-
vide the first line of defense against host-induced antifungal activity. Chitosan is one
of the carbohydrate polymers in the cell wall that significantly affects the outcome
of host-pathogen interaction. Chitosan-deficient strains are avirulent, implicating chi-
tosan as a critical virulence factor. C. gattii R265 is an important fungal pathogen of
concern due to its ability to cause infections in individuals with no apparent im-
mune dysfunction and an increasing geographical distribution. Characterization of
the fungal cell wall and understanding the contribution of individual molecules of
the cell wall matrix to fungal pathogenesis offer new therapeutic avenues for inter-
vention. In this report, we show that the C. gattii R265 strain has evolved alternate
regulation of chitosan biosynthesis under both laboratory growth conditions and
during mammalian infection compared to that of C. neoformans.
KEYWORDS Cryptococcus gattii, R265, chitin, chitosan, chitosan regulation,
protection, vaccine, virulence
Cryptococcosis is an invasive fungal infection caused mainly by the Cryptococcusneoformans and Cryptococcus gattii species. Cryptococcus is ubiquitous with world-
wide distribution and causes infections in a wide variety of host species, such as plants,
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birds, and mammals (1, 2). Infections caused by Cryptococcus may lead to cryptococcal
meningitis and is estimated to cause more than 200,000 deaths annually (3). C.
neoformans (including serotypes A and D) is an opportunistic pathogen and mainly
causes disease in immunocompromised patients (4, 5). However, cryptococcal infec-
tions have also been reported even in healthy individuals (non-HIV) with or without
underlying risk factors (6, 7). Unlike C. neoformans, its sibling species C. gattii (serotypes
B and C) is recognized as a primary pathogen, as it predominately causes infections in
immunocompetent individuals (5, 8–10). C. gattii was initially considered to be endemic
to tropical and subtropical regions, especially Australia until it attracted attention with
a major outbreak on Vancouver Island, British Columbia, Canada, in 1999 (11). Based on
the global molecular epidemiologic survey employing a wide variety of molecular
techniques, five distinct genetic groups (VGI/AFLP4, VGII/AFLP6, VGIII/AFLP5, VGIV/
AFLP7, and VGIV/AFLP10) within the C. gattii species complex were described (12). The
C. gattii R265 strain belongs to the VGII subtype and was the strain associated with the
outbreak in British Columbia in 1999 (13). The fungus subsequently spread to the Pacific
Northwest of the United States (14–16). Infections due to C. gattii R265 are associated
with an 8 to 20% mortality rate in spite of antifungal therapies. With advances in
genotyping, C. gattii distribution has been revised. It is predominantly isolated from
environmental sources and is currently found in a variety of climates, including humid
and arid conditions and associated with 53 different tree species across six continents
(10). It has also been isolated from diverse groups of organisms, including cats, dogs,
marine mammals, koalas, deer, ferrets, llamas, horses, birds, and insects (10). This
distribution to diverse conditions of environment and host species demonstrates its
adaptability.
Significant differences in the ecological, morphological, biochemical, molecular,
pathological, and clinical features exist between C. neoformans and C. gattii species
complex (12, 17). For example, the difference in the assimilation of nitrogen and carbon
sources between C. neoformans and C. gattii species has been exploited to formulate a
one-step diagnostic media for their identification (18). Several differences in the nature
of the host immune response elicited by C. gattii R265 compared to C. neoformans have
been attributed to its capacity to cause disease in persons with apparently normal
immune systems. C. gattii R265 has been shown to proliferate better in macrophages
compared to C. neoformans due to their increased resistance to reactive oxygen species
(ROS) inside macrophages and to their tubular mitochondrial morphology (19). At the
genomic level, strain R265 has shown to evolve by expanding stress-related heat shock
proteins, which may offer better fitness inside the host (20). C. gattii R265 readily
proliferates in the lung and disseminates poorly to the brain, suggesting that unlike C.
neoformans, the major target organ of C. gattii R265 is the host lung (19, 21). C. gattii
R265 has been shown to trigger a dampened immune response in the lung with
reduced infiltration of macrophages, neutrophils, and Th1/Th17 lymphocytes, and it
inhibits host dendritic cell maturity (22–25). Both C. neoformans and C. gattii R265 share
a similar suite of virulence factors, yet they differ in the nature of pathogenesis in
mammalian hosts.
Chitosan is one of the critical components of the cell wall of C. neoformans and has
been shown to be essential for its virulence (26). The genes coding for enzymes that are
responsible for the production of chitosan in C. neoformans have been identified and
characterized (27). Out of the eight potential chitin synthase genes in the genome,
chitin synthase 3 (Chs3) coded by CHS3 and chitin synthase regulator 2 (Csr2) coded by
the CSR2 gene are critical for the production of chitosan (27). There are four potential
chitin deacetylase (CDA) genes in the genome of C. neoformans; three have been shown
to possess chitin deacetylase activity in vegetatively growing cells (28). Chitosan-
deficient strains of C. neoformans induce significant host immune responses during
mammalian infection and clearance of the fungus (26, 29). These results suggest that
the presence of chitosan may influence the cell wall architecture, thereby shielding
pathogen-associated molecular patterns (PAMPs) from being recognized by host im-
mune cells. When grown in yeast extract-peptone-dextrose (YPD) culture medium, all
Lam et al.
September/October 2019 Volume 4 Issue 5 e00644-19 msphere.asm.org 2
 o
n
 N
ovem
ber 14, 2019 at UNIV O
F M
ASS M
ED SCH
http://m
sphere.asm
.org/
D
ow
nloaded from
 
three Cda proteins appear to be functionally redundant. However, they are differentially
regulated in the lungs of the infected host with Cda1 being preferentially expressed
(30). Accordingly, either cda1Δ or the cda mutant with abolished chitin deacetylase
activity were found to be avirulent, suggesting that Cda1 alone with its chitin deacety-
lase activity is sufficient to render the yeast cells fully virulent during a murine infection
of CBA/J mice. Deletion of either Cda2 or Cda3 did not affect the virulence of the yeast
strains (30). These results indicate that in C. neoformans, chitosan and the mechanisms
of its production are the critical mediators of fungal pathogenesis and virulence.
The mechanisms responsible for differences in the pathogenicity and virulence of C.
neoformans and C. gattii are not understood. We sought to determine whether there
are any differences in either the level of cell wall chitosan or in the regulation of its
biosynthesis between these two species. Here, we report the identification of genes
present in C. gattii R265 genome that are either responsible for the production of
chitosan during growth under vegetative conditions or that contribute to chitosan
biosynthesis during mammalian infection. We found significant differences in the
amount and regulation of chitosan biosynthesis between C. gattii R265 and C. neofor-
mans. First, the cell walls of C. gattii R265 had more than double the amount of chitosan
compared to C. neoformans when either grown in culture or in infected mice. We
targeted homologs of C. neoformans chitosan biosynthetic genes in the C. gattii R265
genome for gene deletion and subjected the respective deletion strains to various in
vitro phenotypic assays and to mouse virulence studies. For C. neoformans, Cda1 played
an important role in the synthesis of chitosan, while Cda3 was found to be dispensable
during murine infection. Interestingly for C. gattii R265, we found that Cda3 plays a
critical role in fungal virulence, while the deletion of Cda1 did not affect fungal
virulence across different mouse strains. The results of these studies will provide a
framework to further design strategies to dissect the molecular mechanisms of chitosan
in fungus-induced host immune response and virulence.
RESULTS
Identification of C. gattii R265 genes potentially involved in the synthesis of
chitosan. In C. neoformans, the conversion of chitin to chitosan is catalyzed by Cda1,
Cda2, and Cda3 (28, 30). We utilized BLASTp homology with C. neoformans Cda1, Cda2,
and Cda3 to identify the C. gattii chitin deacetylases in the C. gattii R265 genome. This
search yielded CNBG_1745 (Cda1), CNBG_9064 (Cda2), and CNBG_0806 (Cda3) as the C.
gattii homologs of C. neoformans (Table 1). At the protein level, Cda1, Cda2, and Cda3
are 85%, 83%, and 85% identical and 92%, 90%, and 90% similar, respectively, between
the two species. All three Cda proteins of C. gattii have similar predicted sequence
features to those of C. neoformans Cda proteins in having N-terminal signal sequences,
S/T-rich regions, and glycosylphosphatidylinositol (GPI) anchor sites, as well as con-
served amino acids for catalysis. Pairwise protein sequence alignments are shown in
Fig. S1 in the supplemental material.
C. gattii R265 cells produce significantly larger amount of chitosan in the cell
wall compared to C. neoformans under YPD growth conditions. We have shown for
C. neoformans that the amount of cell wall chitosan significantly influences host
immune response during infection (26, 29). Various studies have demonstrated that
strain R265 elicits different types of immune response either in the host or when
incubated with immune cells under in vitro conditions compared to the response
induced by C. neoformans cells (22–25). Therefore, we were curious to see whether
TABLE 1 Identification of chitin deacetylases in C. gattii R265 genome
Locus tag C. gattii protein
E value for the following query:
C. neoformans Cda1p C. neoformans Cda2p C. neoformans Cda3p
CNBG_1745 Cda1 0.0 4.54E37 4.58E36
CNBG_0964 Cda2 2.07E35 0.0 3.63E29
CNBG_0806 Cda3 1.01E37 2.34E34 0.0
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there is a difference in the amount of chitosan between KN99, a hypervirulent strain of
C. neoformans (31), and R265. To determine the amount of chitosan, we grew both
KN99 and R265 cells in YPD at 30°C. We have previously reported the specific affinity
of an anionic dye Eosin Y to chitosan in C. neoformans (28). Therefore, we stained
wild-type C. neoformans KN99 and C. gattii R265 cells after 5 days of culture. As shown
in Fig. 1A, we observed a dramatic increase in the binding of Eosin Y to R265 cells
compared to KN99 cells. This difference was further quantified by measuring the mean
fluorescence intensity (MFI) per cell using ImageJ (Fig. 1B). The MFI/cell of strain KN99
was 32.9 compared to 62.9 for strain R265. We then measured the total amount of
chitin and chitosan biochemically employing the 3-methyl-2-benzothiazolinone hydra-
zone (MBTH) assay as described in Materials and Methods. Wild-type KN99 and R265
cells were grown for 1 to 5 days. At different days of growth, the cellular chitosan was
quantified by the MBTH assay. As shown in Fig. 1C and D, at day 2, R265 cells started
to show increased amount of chitosan compared to KN99, and this increase peaked at
day 3 of growth before it started to decrease. At its peak, the amount of chitosan as
expressed as nanomoles of glucosamine per milligram (dry weight) of the cell wall
material in the R265 cells had increased by threefold compared to the amount in the
KN99 cells. The levels of chitin in the R265 cells remained almost constant throughout
the growth period, and their levels were comparable to those in the KN99 cells. The
sharp increase in the amount of chitosan observed in R265 on day 3 was not observed
in KN99 cells which showed a slight increase in the chitosan amount (Fig. 1C and D).
These data indicate that outbreak R265 cells produce significantly larger amounts of
chitosan compared to those produced by KN99 cells under YPD growth conditions.
C. gattii R265 cells produce significantly larger amount of chitosan compared
to C. neoformans under host conditions. To determine whether the increased
FIG 1 C. gattii R265 cells produce significantly larger amounts of chitosan in the cell wall compared to
C. neoformans under YPD growth conditions. (A) Wild-type R265 and KN99 strains were grown in YPD for
5 days at 30°C and stained with Eosin Y to detect cell wall chitosan. Staining intensity was assessed using
epifluorescence microscopy with identical exposures for all images. (B) Fluorescent levels for 60 individ-
ual cells (represented in panel A) were quantified using ImageJ (Fiji). The two-tailed unpaired t test with
Welch’s correction was used to compare mean values of the wild type. Means represent the fluorescence
intensity levels from three independent experiments (n 3). ****, P  0.0001. Error bars represent
standard errors of the means. (C) Quantitative determination of cell wall chitosan and chitin of strain
KN99 by the MBTH assay. Cells were grown in YPD for 1 to 5 days, collected, washed, and used for the
assay. Data represents the averages of three biological experiments and are expressed as nanomoles of
glucosamine per milligram (dry weight) of yeast cells. (D) Quantitative determination of cell wall chitosan
and chitin of R265 were determined as in panel C.
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amount of chitosan was also seen under host conditions, we first measured chitosan of
KN99 and R265 cells cultured in tissue culture conditions and then for Cryptococcus
isolated from infected mouse lungs. Wild-type KN99 and R265 cells were first grown in
YPD medium at 30°C and then transferred to RPMI 1640 medium containing 10% fetal
bovine serum (FBS), 5% CO2 at 37°C for 5 days. The cells were then harvested, and the
MBTH assay was used to quantify the chitosan content. As shown in Fig. 2A, R265 cells
have a mean value of 63.9 versus 30.2 of KN99 cells as expressed as nanomoles of
glucosamine sugar per milligram (dry weight) of the cell wall material. Next, chitosan
was determined after isolating the yeast cells from infected mouse lungs. Similar to YPD
and RPMI 1640 culture conditions, R265 cells showed significantly higher cell wall
chitosan compared to KN99 cells with mean values of 213.9 and 78.3, respectively, as
expressed as nanomoles of glucosamine sugar per 108 cells (Fig. 2B). These results
suggest that the increase in cell wall chitosan of C. gattii R265 over C. neoformans KN99
is a phenotype that is preserved when these strains are grown in culture and during
mouse infection.
The deletion of CDA1 in C. gattii R265 causes a decrease in cell wall chitosan
under YPD growth conditions. We generated single CDA deletion mutants of C. gattii
R265 by biolistic transformation. The strains generated and used in this study are listed
in Table 2. The deletion cassettes for each gene deletion were generated by overlap
FIG 2 C. gattii R265 cells produce significantly larger amount of chitosan in the cell wall compared to
C. neoformans under host conditions. (A) Chitosan levels of strains grown in RPMI 1640 containing 10%
FBS and 5% CO2 at 37°C for 5 days. Strains were grown in YPD for 2 days. Yeast cells were harvested,
washed with PBS, inoculated at 500 cells/l in RPMI 1640 containing 10% FBS, and incubated for 5 days
at 37°C in the presence of 5% CO2. At the end of incubation, chitosan was measured by the MBTH assay
and expressed as nanomoles of glucosamine per milligram (dry weight) of cells. Data represent the
averages from three biological experiments. (B) Chitosan levels of strains growing in the murine lung.
Mice (CBA/J) (three mice per group) were intranasally inoculated with 107 CFU of each strain. On day 7
postinfection (PI), the lungs were excised and homogenized, and the lung tissue was removed by alkaline
extraction, leaving the fungal cells to be harvested, counted, and subjected to the MBTH assay. Data are
expressed as nanomoles of glucosamine per 108 cells. Significant differences between the groups were
compared by two-tailed unpaired t test with Welch’s correction. Error bars represent standard errors of
the means. ***, P  0.0062; **, P  0.001.
TABLE 2 Strains used and generated in this study
Strain Resistance marker(s) Background Designation
R265 JLCG924
cda1Δ G418 JLCG924 WLCG1156
cda1Δ–2 G418 JLCG924 WLCG1157
cda2 NAT JLCG924 WLCG1159
cda3 HYG JLCG924 WLCG1162
cda3Δ::CDA3 G418 WLCG1162 JLCG951
cda12 G418/NAT WLCG1156 WLCG1169
cda12Δ–2 G418/HYG WLCG1156 WLCG1171
cda13 G418/HYG WLCG1162 WLCG1197
cda13–2 G418/HYG WLCG1163 WLCG1198
cda23 NAT/HYG WLCG1162 WLCG1166
cda23–2 NAT/HYG WLCG1162 WLCG1167
cda123 G418/NAT/HYG WLCG1166 WLCG1190
cda123–2 G418/NAT/HYG WLCG1166 WLCG1194
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PCR and biolistically transformed into R265 cells. The primers used to generate these
deletion cassettes are listed in Table S1 in the supplemental material. All the isolates
were characterized by diagnostic PCR screening and Southern blot hybridization. After
growing the strains in YPD for 5 days, we measured chitosan by MBTH assay. We found
that deletion of the CDA1 gene decreased the chitosan amount by 33% compared to
that in wild-type R265. However, deletion of either CDA2 or CDA3 did not affect the
total amount of chitosan, as shown in Fig. 3. This is different from what we have
previously described for C. neoformans, where there was no significant difference in
chitosan in any of the single CDA deletion strains (28, 30). This suggests that there are
differences in the regulation of chitin deacetylation between the two species, with R265
Cda1 having a more significant role in chitosan production when the cells were
cultured in YPD.
R265 Cda3 is critical for fungal virulence. Next, we assessed the CDA single-
deletion mutant strains for virulence by employing the murine intranasal infection
model. We infected CBA/J mice with 105 wild-type cells or with cells of the correspond-
ing single CDA deletion strains. The virulence was assayed as described in Materials and
Methods. We found that deletion of either CDA1 or CDA2 did not affect virulence
(Fig. 4A). The virulence of the cda1Δ mutant was reproduced using a second isolate and
FIG 3 The deletion of CDA1 in strain R265 displays a decrease in cell wall chitosan in cells grown in YPD.
Chitosan levels of strains grown in YPD for 5 days were determined. The amount of chitosan in the cell
wall of the strains was quantified by the MBTH assay. Data represent the averages from three biological
experiments with two technical replicates and are expressed as nanomoles of glucosamine per milligram
(dry weight) of yeast cells. Significant differences between the groups were compared by one-way
ANOVA followed by Dunnett’s multiple-comparison test. ***, P  0.0002 comparing wild-type R265 with
any other strain. ns, not significant.
FIG 4 C. gattii cda3Δ displays severely attenuated virulence in CBA/J and C57BL/6 mouse models of
infection. (A) CBA/J mice (6 to 8 weeks old, female) were infected intranasally with 105 CFU of each strain.
Survival of the animals was recorded as mortality of mice for 80 days PI. Mice that lost 20% of the body
weight at the time of inoculation were considered ill and sacrificed. Data are representative of two
independent experiments with five animals for each strain. (B) C57BL/6 mice (4 to 6 weeks old, female)
were infected with 104 CFU of each strain by intratracheal inoculation. Survival of the animals was
recorded as mortality of mice for 50 days PI. Mice that lost 20% of the body weight at the time of
inoculation were considered ill and sacrificed. Data are representative of one experiment with 10 animals
for each strain. Virulence was determined using Mantel-Cox curve comparison with statistical significance
determined by log rank test. P  0.0001 comparing strain KN99 with cda3Δ strain.
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is shown in Fig. S2 to further confirm the absence of a role for Cda1 in the virulence of
C. gattii R265. Interestingly, we found that R265 Cda3 is essential for fungal virulence.
The virulence defect of the cda3Δ mutant was completely restored in a CDA3 comple-
mented strain (Fig. 4A). Since different mouse models show various degrees of sensi-
tivity to Cryptococcus infection, we wanted to verify whether the associations between
the absence of CDA genes, amount of cell wall chitosan, and virulence of the specific
CDA deletion strain can be recapitulated in C57BL/6 mice, which are routinely em-
ployed for diverse immunological studies using readily available mutants. Similar to the
results obtained with CBA/J mice, we found that only the R265 cda3Δ mutant is
specifically avirulent when tested following orotracheal inoculation of 10e4 CFU of
yeast (Fig. 4B). The avirulent phenotype in both mouse strains was accompanied by the
complete clearance of the mutant strain from the infected host at the endpoint of the
survival study (Fig. S3). This was rather surprising because we have previously seen that
for strain KN99, Cda1 plays a major role in fungal virulence without the contribution of
Cda3 to pathogenesis and that C. neoformans cda1 mutant cells persist in the mouse
lungs at low levels, even though the strain does not cause disease (30).
The virulence phenotype of the single CDA deletion strains followed their ability to
grow in the infected lung. As shown in Fig. 5, we found that CBA/J mice infected with
either cda1Δ or cda2Δ strains had lung fungal burdens similar to those of R265 on day
14 and 21 postinfection (PI). On the other hand, mice infected with the cda3Δ strain
showed slow and gradual clearance of the mutant strain. The fungal growth in the
lungs of the mice infected with the cda3Δ strain was restored to wild-type R265 levels
in a CDA3 complemented strain (Fig. 5, cda3Δ::CDA3).
Fungal virulence of different CDA deletion strains is directly correlated with
their ability to produce chitosan under host-mimicking growth conditions. Re-
cently, we have shown that in C. neoformans, Cda1 is essential for fungal virulence, and
this avirulent phenotype is associated with the inability of the mutant to produce
wild-type levels of chitosan when grown under host-mimicking conditions, such as
RPMI 1640 medium containing 10% FBS, 5% CO2, and 37°C (30). Therefore, we wanted
to test whether such defects are also responsible for the avirulent phenotype of R265
mutants that do not harbor the CDA3 gene in the genome. As shown in Fig. 6, the loss
of Cda3 resulted in a 77% decrease in the amount of chitosan produced compared to
wild-type R265. Even though the amount of chitosan in the cda1Δ strain showed 33%
reduction compared to wild-type R265 (Fig. 6), this decrease was similar to what we
observed when the cells were grown in YPD culture conditions as well (Fig. 3). These
data indicate that in strain R265, Cda1-mediated deacetylation of chitin is not influ-
enced by growth conditions and is not critical for virulence. However, Cda3 is respon-
sible for the majority of the deacetylation either in RPMI 1640 culture conditions or in
infected mice and thus contributes significantly to fungal proliferation in the host.
Taken together, these results confirmed the importance of cell wall chitosan to fungal
virulence and suggests that a certain threshold amount of chitosan needs to be
maintained in the cell wall to sustain infection.
FIG 5 There is a slow but gradual clearance of C. gattii cda3Δ in CBA/J mice. Fungal burden in the lungs
of CBA/J mice infected with indicated strains at different days postinfection (DPI). Data are from three
mice per group at each time point. The dotted line indicates the CFU of the initial inoculum for each
strain.
Chitosan and Virulence of C. gattii Strain R265
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Double and triple CDA mutants of C. gattii R265 displayed varied amounts of
chitosan under YPD and host-mimicking conditions. We generated three double
CDA deletion strains and a triple CDA gene deletion strain in C. gattii R265 by biolistic
transformations as indicated in Table 2. We subjected these strains to chitosan quan-
tification after growing them either in YPD or in host-mimicking conditions of RPMI
1640 medium containing 10% FBS in the presence of 5% CO2 at 37°C. When we
compared the chitosan amounts among the CDA double deletion strains, we found
that the cell wall chitosan amount was significantly decreased in all the double deletion
strains grown under YPD culture conditions (cda12Δ, cda13Δ, and cda23Δ strains
in Fig. 7A). The decrease in the chitosan amount was more pronounced in the absence
of Cda1 in combination with either Cda2 or Cda3: 63% reduction for the cda12Δ strain
and 54% reduction for the cda13Δ strain compared to wild-type R265. The amount of
chitosan in the cda23Δ strain showed a reduction of only 26% compared to wild-type
R265. These results are consistent with the major role of Cda1 in chitosan production
in strain R265 when the cells were grown under YPD conditions (Fig. 3). When we
deleted all three CDAs to generate a cda1Δ2Δ3Δ strain, the chitosan amount decreased
to almost negligible amounts, suggesting that in spite of differences in the roles of
individual CDAs in strains KN99 and R265, the deletion of all three CDAs was sufficient
to render the mutant chitosan deficient (Fig. 7A). When the strains were grown under
host-mimicking conditions (RPMI 1640 plus 10% FBS grown with CO2 at 37°C), any
strain in which CDA3 was deleted in combination with either CDA1 or CDA2 (cda1Δ3Δ
or cda2Δ3Δ strain in Fig. 7B) produced negligible amounts of chitosan similar to the
cda1Δ2Δ3Δ strain, further indicating the importance of R265 Cda3 in the production of
chitosan in the host and its subsequent effect on fungal virulence.
Chitosan-deficient R265 cells were sensitive to cell wall stressors and had
normal capsule- and melanin-producing abilities. We subjected the single CDA
deletion strains and the triple CDA deletion strain of C. gattii R265 to a panel of cell wall
stressors (0.005% SDS, 1 mg/ml Calcofluor white, 0.5 mg/ml caffeine, 0.4% Congo red)
added to YPD agar medium; these stressors are routinely employed to determine cell
wall integrity. As shown in Fig. S4, only the chitosan-deficient cda1Δ2Δ3Δ strain was
FIG 6 C. gattii Cda3 plays a major role in the synthesis of chitosan under host infection conditions.
Chitosan levels of strains grown in RPMI 1640 containing 10% FBS and 5% CO2 at 37°C for 5 days. The
indicated strains were grown in YPD for 48 h. Yeast cells were harvested, washed with PBS, and
inoculated at 500 cells/l in RPMI 1640 containing 10% FBS and incubated for 5 days at 37°C in the
presence of 5% CO2. At the end of incubation, chitosan was measured by the MBTH assay and expressed
as nanomoles of glucosamine per milligram (dry weight) of cells. Data represent the averages from three
biological experiments. Significant differences between the groups were compared by one-way ANOVA,
followed by Dunnett’s multiple-comparison test (***, P 0.0002, *, P 0.0280 comparing KN99 with any
other strain; ns, not significant).
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sensitive to the various cell wall stressors. None of the CDA deletion mutants were
sensitive to temperature when their growth at 30°C was compared to growth at 37°C
on YPD agar medium. The deletion of CDA genes in strain R265 either individually or
in combination did not affect their ability to produce either capsule (Fig. S5) or melanin
as shown in Fig. S6. In contrast to C. neoformansmutants (26), none of the CDA mutants
of R265 displayed “leaky melanin” phenotype.
R265 CDA1 and CDA2 are dispensable for virulence even when both genes
were deleted. We next subjected the double and triple CDA gene deletion strains to
tests of fungal virulence either by intranasal infection of CBA/J mice or by orotracheal
inoculation of C57BL/6 mice. We found that deletion of CDA1 and CDA2 did not affect
the virulence in either CBA/J or C57BL/6 mice (cda1Δ2Δ strain in Fig. 8A and B).
Consistent with the role of C. gattii R265 Cda3 in virulence, double CDA deletion strains
in which CDA3 is deleted in combination with either CDA1 or CDA2 showed a major
defect in virulence (cda1Δ3Δ and cda2Δ3Δ strains in Fig. 8A and B). These results further
point to the importance of just Cda3 in fungal virulence for strain R265. The mutant
FIG 7 The deletion of C. gattii CDA1, CDA2, and CDA3 results in a strain that is completely chitosan
deficient. C. gattii Cda1 in combination with Cda2 or Cda3 plays a major role in chitosan synthesis in
vegetative growing conditions. While C. gattii Cda3 in combination with Cda1 or Cda2 results in a stain
that is completely chitosan-deficient. (A) Chitosan levels of strains grown in YPD. The indicated strains
were grown in YPD for 5 days. The amount of chitosan in the cell wall of the strains was quantified by
the MBTH assay. Data are the averages for three biological experiments and are expressed as nanomoles
of glucosamine per milligram (dry weight) of yeast cells. (B) Chitosan levels of strains grown in RPMI 1640
containing 10% FBS and 5% CO2 at 37°C for 5 days. The indicated strains were grown in YPD for 48 h.
Yeast cells were harvested, washed with PBS, and inoculated at 500 cells/l in RPMI 1640 containing 10%
FBS and incubated for 5 days at 37°C in the presence of 5% CO2. At the end of incubation, chitosan was
measured by the MBTH assay and expressed as nanomoles of glucosamine per milligram (dry weight) of
cells. Data represent the averages for three biological experiments. Significant differences between the
groups were compared by one-way ANOVA, followed by Dunnett’s multiple-comparison test (****, P 
0.0001, comparing KN99 with any other strain; ns, not significant).
FIG 8 Deletion of C. gattii CDA3 in combination with any of the other two CDAs results in severe
attenuation of virulence in CBA/J and C57BL/6 mouse models of infection. (A) CBA/J mice (6 to 8 weeks
old, female) were infected intranasally with 105 CFU of each strain. Survival of the animals was recorded
as mortality of mice for 80 days postinfection (PI). Mice that lost 20% of the body weight at the time of
inoculation were considered ill and sacrificed. Data are representative of two independent experiments
with five animals for each strain. (B) C57BL/6 mice (4 to 6 weeks old, female) were infected intratracheally
with 104 CFU of each strain. Survival of the animals was recorded as mortality of mice for 50 days PI. Mice
that lost 20% of the body weight at the time of inoculation were considered ill and sacrificed.
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strain devoid of all three CDA genes (cda1Δ2Δ3Δ strain) was completely avirulent
(Fig. 8A and B). For all mutants, the avirulent phenotype of the mutant strains was
accompanied by the inability of the different CDA mutant strains to proliferate or
maintain in the infected murine lung as revealed by their gradual clearance (data not
shown). To further ascertain these results, we subjected a second independent isolate
of each mutant to fungal virulence studies and obtained nearly identical results
(Fig. S7).
Vaccination with the chitosan-deficient R265 cells confers partial protection to
subsequent challenge with the virulent wild-type R265. For C. neoformans, we
observed that mice infected with 107 CFU of the chitosan-deficient cda1Δ2Δ3Δ strain
resulted in the clearance of the mutant. That clearance was accompanied by the
induction of a robust protective response to a subsequent infection with wild-type, fully
virulent KN99 (29). This protective response was observed only when mice were
vaccinated with 107 CFU of the cda1Δ2Δ3Δ strain, while vaccination with either 106 or
105 CFU did not generate a protective response (29). Therefore, since the complete
clearance of the chitosan-deficient cda1Δ2Δ3Δ strain is also observed for mutants
generated in the R265 background, we wanted to determine whether this clearance of
the mutant strain induces protective immunity to R265 infection. For this, we vacci-
nated naive mice (CBA/J) with either 105, 106, or 107 CFU of live preparations of the
cda1Δ2Δ3Δ strain by intranasal inhalation. After 40 days PI, we challenged them
with 105 CFU of strain R265. Two independent isolates of the cda1Δ2Δ3Δ strain
(cda1Δ2Δ3Δ–1 and cda1Δ2Δ3Δ-2) were used for this study. As shown in Fig. 9A,
vaccination with either one of the chitosan-deficient cda1Δ2Δ3Δ isolates conferred only
FIG 9 Vaccination of CBA/J mice with 107 CFU of live or heat-killed (HK) cda1Δ2Δ3Δ cells conferred
attenuated protective immunity to subsequent infection with wild-type R265 C. gattii cells. (A) Mice were
immunized with either 107, 106, or 105 live CFU of cda123Δ cells through inhalation. PBS-inoculated
mice served as control. Animals were left for 40 days to resolve the infection. Subsequently, both groups
of mice were challenged with 50,000 CFU of virulent R265 cells. Virulence was recorded as mortality of
mice. Mice that lost 20% of starting body weight at the time of inoculation were considered to be
moribund and sacrificed. The percentage of mice that survived was plotted against the day postinfection.
Each survival curve is the average of two independent experiments that had five mice per experimental
group. (B) Mice were immunized with an inoculum of HK cells with a dose equivalent to 107 CFU of either
the wild-type R265 or the cda123Δ strain. Control mice were inoculated with PBS. After 40 days, mice
were challenged with 50,000 CFU of wild-type R265 cells. Survival of the animals was recorded as
described above. The data shown are from a single experiment with five mice per experimental group.
A second experiment showed similar results.
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partial protection to subsequent infection with R265. The control mice that received
phosphate-buffered saline (PBS) alone succumbed to R265 infection with a median
survival time of 20 days PI. However, the mice vaccinated with a live preparation of the
cda1Δ2Δ3Δ strain had a median survival time of 30 to 40 days PI upon secondary
challenge infection with strain R265. This protective immunity required a minimal dose
of 107 CFU of the cda1Δ2Δ3Δ strain for vaccination (Fig. 9A), as observed for the
cda1Δ2Δ3Δ mutant of strain KN99 (29). Next, we wanted to determine whether a
heat-killed (HK) preparation of the cda1Δ2Δ3Δ strain induces protective immunity. We
confirmed that incubating live R265 (either the wild-type strain or the corresponding
cda1Δ2Δ3Δ mutant) at 70°C for 15 min was sufficient to kill both strains by plating them
for CFU onto YPD agar. Then we vaccinated mice intranasally with 107 CFU of HK
preparation of either strain R265 or the cda1Δ2Δ3Δ mutant, waited 40 days, and
challenged them with 105 CFU of R265. The mice vaccinated with either PBS or with HK
wild-type R265 succumbed to R265 infection with a median survival time of 20 days PI.
However, the mice vaccinated with the HK cda1Δ2Δ3Δ strain had a median survival
time of 33 days PI (Fig. 9B), similar to that observed for vaccination with the live
cda1Δ2Δ3Δ strain (Fig. 9A). When the vaccination and protection experiment was done
in C57BL/6 mice using the HK cda1Δ2Δ3Δ strain as a vaccine, mice had a median
survival time of 41.5 days compared to 26 days for unvaccinated mice (Fig. S8).
DISCUSSION
Chitosan is one of the principal components of the C. neoformans cell wall. In its
absence, yeast cells display a severe budding defect resulting in irregular shaped, often
clumped cells with significant sensitivity to various cell wall-perturbing agents (28).
More importantly, the absence of chitosan makes the yeast cells completely avirulent
in a mammalian host, as the chitosan-deficient cells stimulate robust host immune
responses, which in turn leads to rapid clearance of infection (26, 29). The outbreak
strain of C. gattii, R265, is a hypervirulent strain that has been reported to possess
several key features that enabled it to cause symptomatic infection, even in immuno-
competent individuals (10, 32, 33). Its higher rate of intracellular proliferation with
increased resistance to oxidative stress, its ability to dampen host immune response,
and its potential to inhibit the maturation of specific immune cells all may contribute
to its virulence (19, 22–25, 34, 35). A larger amount of chitosan in C. gattii R265 than in
C. neoformans KN99 may efficiently shield surface-exposed PAMPs from being recog-
nized by the host immune system, thereby limiting the intensity and complexity of the
host immune response. C. neoformans and C. gattii share diverse ecological niches.
Moreover, C. gattii R265 is predominantly detected in the environment and strictly
associated with plants where they encounter chitinases from soil microbes and plant
hosts, respectively (32). Extensive deacetylation of chitin to form chitosan may provide
greater resistance to environmental chitinases, thereby increasing its fitness in the
environment.
C. neoformans Cda1 plays an important role in the deacetylation of chitin especially
during host infection (30). Among the individual C. neoformans CDA deletion strains, we
did not observe phenotypic differences when the strains were cultured in YPD medium,
suggesting the redundancy in their function (28). However, deletion of Cda1 alone
caused a dramatic avirulent phenotype in virulence studies using CBA/J mice (30).
Unlike C. neoformans, Cda1 of C. gattii seems to play an important role in deacetylation
when grown in YPD medium, since its deletion caused a 34% reduction in the amount
of cell wall chitosan (Fig. 3). The deletion of either CDA2 or CDA3 did not significantly
reduce the chitosan amount when the strain was grown in YPD. However, when grown
under host-mimicking conditions of RPMI 1640 medium with 10% FBS, 5% CO2, and at
37°C, C. gattii Cda3 played an important role in the deacetylation of chitin, since its
deletion in the cda3Δ strain caused a 76% reduction in the amount of chitosan. On the
other hand, the decrease in the amount of chitosan in the cda1Δ strain when grown in
RPMI 1640 conditions was around 32%, which is similar to what we observed for YPD
culture conditions, suggesting a unique role of R265 Cda3 in deacetylating chitin in
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host-mimicking conditions. For our initial animal virulence experiments, we chose two
independent isolates of the cda1Δ mutant strain, expecting that they will mimic the
avirulent phenotype observed in C. neoformans (30). However, we were surprised to see
that for C. gattii R265, deacetylation of chitin during host infection was even more
dependent on Cda3 than Cda1. The avirulent phenotype of the cda3Δ mutant was
further confirmed by the CDA3 complemented strain in CBA/J mice. In spite of its role
in chitosan production in YPD and host-mimicking media, the decreased levels of
chitosan in the cda1Δ strain did not affect its virulence (Fig. 4). It may be that the levels
of chitosan present in the cda1Δ strain during infection are still sufficient to promote
pathogenesis, or the pattern of deacetylation in the chitosan produced by Cda1 may be
different from that of Cda3. This difference in the molecular structure of chitosan may
have contributed to the observed differences in the virulence potential of different CDA
deletion mutant strains.
All three CDAs contribute to chitosan production in C. gattii R265 while growing in
YPD, since deletion of two CDA genes in combination significantly reduced cell wall
chitosan (Fig. 7). This again was reflected in the virulence phenotype of the double and
triple CDA deletion strains. When CDA3 was deleted in combination with any one or
both of the other CDA genes, the resulting strains had substantially reduced chitosan
when grown in host-mimicking conditions and were avirulent. Any strain in which CDA3
is deleted was avirulent in both CBA/J and C57BL/6 mouse strains and was cleared from
the infected lung. Deletion of all three CDAs made the strain chitosan deficient similar
to the cda1Δ2Δ3Δ strain of C. neoformans. The majority of the in vitro phenotypes of the
cda1Δ2Δ3Δ strain of R265 were similar to the cda1Δ2Δ3Δ strain made in C. neoformans.
However, cda1Δ2Δ3Δ of C. gattii R265 grew better in YPD (with markedly fewer
morphological abnormalities) than the cda1Δ2Δ3Δ strain of C. neoformans (data not
shown). C. neoformans cda1Δ2Δ3 exhibited a leaky melanin phenotype when incubated
in medium containing L--DOPA (28). However, the cda1Δ2Δ3Δ strain of R265 did not
show this phenotype (Fig. S6) suggesting that there are differences in the cell wall
architecture between cda1Δ2Δ3Δ cells of C. neoformans and C. gattii.
In C. neoformans, CDA1 seems to be the most critical deacetylase gene during
infection—the CDA1 gene is much more highly upregulated during the growth of
wild-type KN99 yeast cells in the infected lung than CDA2 or CDA3, and a cda1 strain
is avirulent, consistent with the hypothesis that differential regulation of CDA1 is the
driving force behind its importance during infection (30). Unlike C. neoformans, CDA3 is
the critical deacetylase gene in C. gattii R265 based on our genetic analysis, but the
available data from genome-wide studies of transcriptional regulation are less clear,
and may be different for different C. gattii strains. One study that looked only at
transcript abundance of genes from strain R265 recovered through bronchoalveolar
lavage, found that R265 CDA3 was among the highly expressed genes during mam-
malian infection (36). Recent whole-genome transcriptome studies of different strains
of C. gattii have shown multiple strain-specific differences in gene expression that
include chitin and chitosan biosynthesis genes (37, 38). One of these studies (37)
examined strains from the four lineages of C. gattii, and it showed that the CDA2 gene
of strain R265 was substantially downregulated after incubation of the R265 cells with
bone marrow-derived macrophages. The results from these studies suggest that tran-
scriptional regulation of chitin and chitosan biosynthesis in C. gattii is likely divergent
from regulation in C. neoformans, is different among different C. gattii strains, may play
a role in the virulence of the different strains, and could be a factor in the importance
of CDA3 in strain R265.
We have previously shown that vaccination with the chitosan-deficient cda1Δ2Δ3Δ
strain of C. neoformans at the optimal concentration confers robust protective immu-
nity to subsequent challenge infection with the wild-type virulent KN99 strain (29).
Even though deletion of all three CDA genes of C. gattii produced a chitosan-deficient
strain, vaccination with either the live strain or a heat-killed preparation of it induced
only partial protection to subsequent infection with strain R265. This may be due to the
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fact that R265 has the inherent ability to dampen host-induced immune responses
(22–25).
In summary, the hypervirulent C. gattii strain R265 has evolved with a distinct
transcriptional profile with altered expression of components of chitin deacetylation
that may have enabled it to adapt more efficiently to various environmental conditions
with ramifications on its virulence. Of the several reported differences in the virulence-
related traits between C. neoformans and C. gattii R265, the difference in the regulation
of chitosan biosynthesis as revealed from our studies may significantly contribute to the
mechanisms of its unique and distinct nature of pathogenesis, since chitosan is one of
the macromolecules that resides at the host-pathogen interface.
MATERIALS AND METHODS
Fungal strains and media. R265, C. gattii strain of VGII subtype linked to the 1999 outbreak in British
Columbia, Canada (11), was used as the wild-type strain and as progenitor of mutant strains. This strain
was kindly provided by Joseph Heitman (Duke University Medical Center, NC). All the strains used in this
study are listed in Table 1. KN99, a strain of C. neoformans, was used as the wild-type strain for serotype
A (31). Strains were grown on YPD (1% yeast extract, 2% Bacto peptone, and 2% dextrose). Solid media
contained 2% Bacto agar. Selective YPD medium contained 100 g/ml nourseothricin (NAT) (Werner
BioAgents, Germany) and/or 200 g/ml G418 (Geneticin; Gibco Life Technologies, USA). RPMI 1640
medium (catalog no. 10-040-CM; Corning) contained 10% fetal bovine serum (FBS) (catalog no. 26140;
Gibco-Thermo Fisher Technologies).
Generation of deletion constructs of C. gattii. Gene-specific deletion constructs of the chitin
deacetylases were generated using overlap PCR gene technology described previously (39, 40) and
included either the hygromycin resistance, Geneticin resistance cassette (41), or nourseothricin resistance
cassette (42). The primers used to disrupt the genes are shown in Table S1 in the supplemental material.
The Cda1 deletion cassette contained the Geneticin resistance cassette, resulting in a 1,539-bp replace-
ment of the genomic sequence between regions of primers 3-Cda1 and 6-Cda1 shown in upper case in
Table S1. The Cda2 deletion cassette contained the hygromycin resistance cassette, resulting in a
1,587-bp replacement of the genomic sequence, and the Cda3 deletion cassette contained the hygro-
mycin resistance cassette, resulting in a 1,494-bp replacement of the genomic sequence. Constructs were
introduced into the R265 strain using biolistic techniques (43).
Transformation and characterization of C. gattii mutants. Recipient strains of C. gattii were
transformed biolistically following the protocol described earlier (41, 43). Drug-resistant transformants
that formed colonies in 3 to 5 days were passaged four times in liquid YPD medium before reselection
of drug resistance on agar. Transformants were further screened by diagnostic PCR of their genomic DNA
using primers at the 5= and 3= junction of the integration site of the transforming DNA. Southern blot
hybridizations were done to verify the absence of random DNA integrations, as described previously
employing digoxigenin (DIG)-labeled DNA probes (44, 45).
Cellular chitosan measurement. As previously described, MBTH (3-methyl-2-benzothiazolinone
hydrazone)-based chemical method was used to determine the chitin and chitosan content of C. gattii
or C. neoformans (31). In brief, cells were collected after growing them in appropriate media and growth
conditions by centrifugation. The cell pellets were washed two times with phosphate-buffered saline
(PBS), pH 7.4, and lyophilized. The dried samples were resuspended in water first before adding KOH to
a final concentration of 6% KOH (wt/vol). The alkali-suspended material was incubated at 80°C for 30 min
with vortexing in between to eliminate nonspecific MBTH-reactive molecules from the cells. Alkali-
treated material was then washed several times with PBS, pH 7.4, to make sure that the pH of the cell
suspension was brought back to neutral pH. In the case of the cells grown in RPMI 1640 medium,
alkali-treated material was sonicated as described previously to generate a uniform suspension (30).
Finally, the cell material was resuspended in PBS, pH 7.4, to a concentration of 10 mg/ml in PBS (by dry
weight), and a 0.1-ml aliquot of each sample was used in the MBTH assay (46).
Virulence and fungal burden assays. C. gattii strains were grown at 30°C and 300 rpm for 48 h in
50 ml YPD. The cells were centrifuged, washed in endotoxin-free 1 PBS, and suspended in 5 ml of the
same PBS solution. The cells were counted with a hemocytometer and diluted to 2 106 cells/ml. CBA/J
female mice (Jackson Laboratories) were anesthetized with an intraperitoneal injection (200 l) of
ketamine (8 mg/ml)-dexmedetomidine (0.05 mg/ml) mixture, which was reversed by an intraperitoneal
injection of 200 l of antipamezole (0.25 mg/ml). Mice were allowed to inhale 1 105 cells in 50 l,
which were dripped into the nares. For virulence assays, mice were weighed before and during the
course of infection. Mice were euthanized by CO2 asphyxiation if they reached 80% of their original body
weight. At this point, the mice appeared morbidly ill, displaying a ruffled coat, lethargy, hunched posture,
unstable gait, and loss of appetite. For the determination of CFU, lung or brain from each mouse was
placed in 2.0 ml of 1 PBS (pH 7), homogenized, serially diluted, plated onto YPD agar supplemented
with 100 g/ml streptomycin and 100 g/ml ampicillin, and incubated for 2 days at 30°C. Total CFU per
organ were calculated. The infection protocol was reviewed and approved by the Washington University
School of Medicine Animal Care and Use Committee (IACUC).
Evaluation of C. gattii to stress under in vitro conditions. Solid YPD medium was made with the
desired amount of either SDS, NaCl, Calcofluor white, or Congo red. For plating, wild-type and mutant
strains were grown in liquid YPD for 24 h at 30°C. Cells were diluted to an optical density at 650 nm
(OD650) of 1.0, and 10-fold serial dilutions were made. Five microliters of each dilution was spotted on the
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plate, and the plates were incubated for 2 or 3 days at appropriate temperatures and photographed.
Eosin Y staining was conducted as described earlier (29).
Analysis of melanin production. Strains were grown overnight in 2 ml YPD medium at 30°C with
shaking to saturation. Cells were collected and washed in 1 PBS. Then, 1 108 (5 107/ml) of each
mutant was added to 4 ml of glucose-free asparagine medium (1 g/liter L-asparagine, 0.5 g/liter
MgSO4·7H2O, 3 g/liter KH2PO4, and 1 mg/liter thiamine, plus 1 mM L-3,4-dihydroxyphenylalanine [L-
DOPA]) for 7 days at 300 rpm and 30°C in the dark. Samples were then spun down at 600 g for 10
min. The cells’ ability to produce pigment was assessed visually.
Capsule analysis. Cells were grown in YPD at 30°C. After 48 h for growth, cells were collected,
washed once with PBS, inoculated into RPMI 1640 medium containing 10% fetal bovine serum (FBS) at
a concentration of 500 cells/l, and incubated for 5 days at 37°C in the presence of 5% CO2. The
capsule-induced strains were resuspended in a 1:4 India ink-H2O solution and photographed on an
Olympus BX61 microscope. The capsule diameter was measured and averaged for a minimum of 100
cells per strain using SlideBook 5.0 (Intelligent Imaging Innovations, Inc. CO, USA).
Statistics. Data were analyzed using GraphPad Prism, version 7.0 (GraphPad Software, Inc., La Jolla,
CA). The unpaired two-tailed t test with Welch’s correction was used for comparisons of two groups. The
one-way analysis of variance (ANOVA) with the Dunnett’s multiple-correction test was used to compare
more than two groups. Kaplan-Meier survival curves were compared using the Mantel-Cox log rank test.
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